Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial.

Farsad EskandaryMichael DürrKlemens BuddeKonstantin DobererRoman Reindl-SchwaighoferJohannes WaiserMarkus WahrmannHeinz RegeleAndreas SpittlerNils LachmannChrista FirbasJakob MühlbacherGregor BondPhilipp F HalloranEdward ChongBernd JilmaGeorg A Böhmig

Published in: Trials (2019)

ClinicalTrials.gov, NCT03444103 . Registered on 23 February 2018 (retrospective registration).

Keyphrases

study protocol
randomized controlled trial
cross sectional
clinical trial
open label
double blind